Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07040202

Immune Responses to Dengue and Sepsis

Evaluating Immune Responses to Dengue and Sepsis in Hospitalized Patients in Cambodia

Status
Recruiting
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Institut Pasteur du Cambodge · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Accepted

Summary

The goal of this research study is to help the investigators better understand serious dengue disease. The investigators will collect clinical information and up to four blood samples from participants with dengue, sepsis, or healthy people. The investigators will perform multiple analyses on the blood samples and compare results between dengue patients and those with sepsis and healthy people.

Detailed description

This is an observational study enrolling n=200 hospitalized individuals with dengue-like illness, n=30 individuals with sepsis, and n=10 healthy controls to evaluate immune responses in plasma leak syndromes. Sepsis and dengue patients will have blood collected at enrollment, day 1, and day 3, and dengue patients will have an additional blood draw at day 21. Healthy participants will have a single blood draw at enrollment. The blood collected will enable the evaluation of immune kinetics, including changes in neutrophils, cytokines, and adaptive responses, as dengue progresses or improves. Overall, this study will facilitate the evaluation of an understudied cell type and will provide unique data for understanding the temporal changes in the immune response to dengue virus. A better understanding of dengue pathophysiology will help identify potential therapeutic targets to improve outcomes in this disease.

Conditions

Timeline

Start date
2025-06-02
Primary completion
2025-11-01
Completion
2026-12-01
First posted
2025-06-27
Last updated
2025-06-27

Locations

3 sites across 1 country: Cambodia

Source: ClinicalTrials.gov record NCT07040202. Inclusion in this directory is not an endorsement.